Basho, Reva K <br/><br/>
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.  [electronic resource] 

 -  The oncologist  11 2018 
 - 1300-1309 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2017-0498  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Humans<br/>Middle Aged<br/>Prognosis<br/>TOR Serine-Threonine Kinases--genetics<br/>Triple Negative Breast Neoplasms--drug therapy